Castellanos-Cruz MC, Mejía-Albarrán ME, Jiménez-Tapia Y, Pichardo-Villalón L, Franco-Hernández MI, Alcázar-López V, De León-Ham A, Tapia-Madrigal L, Hernández-Sánchez J, López-Martínez B, Parra-Ortega I

Language: Spanish
References: 11
Page: 50-53
PDF size: 274.70 Kb.

ABSTRACT

Introduction: Response times to clinical areas in the identification of pathogens are fundamental to establish an adequate treatment in patients, in the case of microbiological diagnosis there are multiple variables that can affect the timely delivery of results. Material and methods: The performance of the Vitek 2 XL automated equipment was verified in the Clinical Bacteriology laboratory of the HIMFG by a prospective study from June to November 2014. The recording of the information was performed in an antimicrobial susceptibility test format, the microorganisms were isolated of different biological samples, from the patients of the various HIMFG rooms. Results: 3,410 identification cards were analyzed, of which 1,965 were Gram negative, having an average identification time of 5.25 hours. For Gram positive, 1,135 cards were used, with an average identification time of 4.58 hours, for susceptibility to antimicrobials for Gram negative the average time was 10 hours and for Gram positive an average time of 9.95 hours, 68.7% of the Strains identified had excellent yield, 15.65% very good, 3.72% good and 1.29 acceptable. Conclusions: With the above we can consider quality standards based on the identification and antimicrobial susceptibility times and also the additional requirements to be able to identify genus and species in the pediatric population of our hospital.

REFERENCES

1. Kilgore ML, Steindel SJ, Smith JA. Evaluating stat testing options in an academic health center: therapeutic turnaround time and staff satisfaction. Clin Chem. 1998; 44: 1597-1603.

2. Hawkins RC. Laboratory turnaround time. Clin Biochem Rev. 2007; 28: 179-194.

3. Howanitz JH, Howanitz PJ. Laboratory results: timeliness as a quality attribute and strategy. Am J Clin Pathol. 2001; 116: 311-315.

4. Stotler BA, Kratz A. Determination of turnaround time in the clinical laboratory: “accessioning-to-result” time does not always accurately reflect laboratory performance. Am J Clin Pathol. 2012; 138: 724-729.

5. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. M100-S22, Vol 32, No. 3 replaces M100-S21, Vol. 31, No. 1, Wayne, PA: CLSI. January 2012.

6. López-Martínez B, Calderón-Jaimes E, Olivar-López V, Parra-Ortega I, Alcázar-López V, Castellanos-Cruz MC y cols. Susceptibilidad antimicrobiana de microorganismos causantes de infección de vías urinarias bajas en un hospital pediátrico. Bol Med Hosp Infant Mex. 2014; 71 (6): 339-345.

7. Calderón-Jaimes E, Casanova-Román G, Galindo-Fraga A, Gutiérrez-Escoto P, Landa-Juárez S, Moreno-Espinosa S y cols. Diagnóstico y tratamiento de las infecciones en vías urinarias: un enfoque multidisciplinario para casos no complicados. Bol Med Hosp Infant Mex. 2013; 70: 3-10.

8. Hata L, Hall L, Fothergill A, Larone D, Wengenack N. Multicenter evaluation of the new Vitek 2 advanced colorimetric yeast identification card. J Clin Microbiol. 2007; 45: 1087-1092.

9. Koehler AP, Chu KC, Houang ET, Chemg AF. Simple, realiable, and cost effective yeast identification scheme for the clinical laboratory. J Clin Microbiol. 1999; 37 (2): 422-426.

10. Sanguinetti M, Porta R, Sali M, La Sorda M, Pecorini G, Fadda G et al. Evaluation of Vitek 2 and RapID Yeast Plus System for yeast species identification: experience at a large clinical microbiology laboratory. J Clin Microbiol. 2007; 45: 1343-1346.

11. VITEK.TWO® Manual del Usuario. Información de Producto de los sistemas BioMérieux®Inc Durham, North Carolina 27704-0969/USA.